|
Chronic Lymphocytic Leukemia Patient Management Simulator |
|
06/08/2020 - 12:00am to 06/08/2021 - 12:00am |
|
BCOP Test - The Role of the Pharmacist in Smoking Cessation and Education of Patients with Cancer |
|
06/08/2020 - 1:00pm to 06/08/2021 - 12:00am |
|
Sequencing Therapy for Patients with Lung Cancer |
0.75 |
06/09/2020 - 12:00am to 03/01/2021 - 12:00am |
|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020 |
1.00 |
06/10/2020 - 12:00am to 06/10/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: The Role of the Pharmacist in Smoking Cessation and Education of Patients with Cancer |
1.00 |
06/10/2020 - 12:00am to 06/08/2021 - 12:00am |
|
Evidence-Based Approaches to Smoking Cessation in Patients with Cancer |
0.50 |
06/16/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Head and Neck Cancer |
1.00 |
06/17/2020 - 12:00am to 10/25/2020 - 12:00am |
|
Key Considerations in Adopting a Value-Based Payment Model |
0.50 |
06/25/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Use of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Real-World Issues |
1.00 |
06/25/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Optimizing the Management of Endometrial Cancer |
0.50 |
07/01/2020 - 12:00am to 03/01/2021 - 12:00am |
|
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance |
1.75 |
07/02/2020 - 12:00am to 07/02/2021 - 12:00am |
|
Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer |
1.00 |
07/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Optimizing Treatment for Head and Neck Cancers |
1.50 |
07/09/2020 - 12:00am to 03/01/2021 - 12:00am |
|
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020 |
1.00 |
07/10/2020 - 12:00am to 07/10/2021 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer |
0.75 |
07/13/2020 - 12:00am to 07/13/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward